Table 1 Characteristics of individual patients.
Baseline clinicopathological characteristics | |||
|---|---|---|---|
Age (years), mean ± SD | 72.8 ± 9.1 | Histology (differentiation), n (%) | |
Sex, n (%) | Differentiated | 16 (53.3) | |
Male | 26 (86.7) | Undifferentiated | 14 (46.7) |
Female | 4 (13.3) | Histology (Lauren classification), n (%) | Â |
Locus, n (%) | Intestinal | 19 (63.3) | |
GE | 2 (6.7) | Diffuse | 1 (3.3) |
U | 9 (30.0) | Mixed | 9 (30.0) |
M | 8 (26.7) | Indeterminant | 1 (3.3) |
L | 11 (36.7) | HER2 status, n (%) | |
Macroscopic type (Borrmann), n (%) | Positive | 7 (23.3) | |
1 | 2 (6.7) | Negative | 21 (70.0) |
2 | 14 (46.7) | Unknown | 2 (6.7) |
3 | 11 (36.7) | Helicobacter pylori infection, n (%) | |
4 | 2 (6.7) | Positive | 20 (66.7) |
5 | 1 (3.3) | Negative | 10 (33.3) |
pStage, n (%) | Molecular classification by TCGA, n (%) | ||
I | 4 (13.3) | MSI | 5 (16.7) |
II | 7 (23.3) | EBV | 3 (10.0) |
III | 14 (46.7) | GS | 4 (13.3) |
IV | 5 (16.7) | CIN | 18 (60.0) |
| Â | Â | Mesenchymal subtype by ACRG, n (%) | |
| Â | Â | Mesenchymal | 6 (20.0) |
| Â | Â | Non-mesenchymal | 24 (80.0) |
